SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Mizuho Maintains Neutral on Neurocrine Biosciences, Raises Price Target to $105

Mizuho maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Neutral and raises the price target from $103 to $105.

Benzinga · 05/07/2020 15:36

Mizuho maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Neutral and raises the price target from $103 to $105.